News Sentiment

TDOC sentiment intelligence

Teladoc Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 56 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 9.28 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 56

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+0.9% over one week, +26.4% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Teladoc Health to announce Q2 2026 results on July 29

Market Reaction

Balanced read

51/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction 0.9% Price digesting
Trend fit Trend active 26.4% over four weeks
Fair value -15.9% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 32
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 56
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
simplywall.st 6
Stock Titan 5
TradingView 3
Simply Wall St. 3
Simply Wall Street 2
Investing.com 2
Sahm 2

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 11
Deals and strategy 6
Analyst action 6
Balance sheet 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-56 of 56
GlobeNewswire Direct company coverage

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08

Teladoc Health, Inc. announced an inducement award to David Packles, the new Head of Product for BetterHelp. This award, effective July 1, 2026, consists of 50,000 restricted stock units that will vest over three years based on continued service. The award was granted under the T

Tone
Positive 62/100
Event
Market update
Published
03 Jul 2026 20:40
Source
GlobeNewswire
The Globe and Mail Direct company coverage

Analysts Offer Insights on Healthcare Companies: Incyte (INCY) and Teladoc (TDOC)

Truist Financial analysts have maintained "Hold" ratings on both Incyte (INCY) and Teladoc (TDOC). For Incyte, analyst Srikripa Devarakonda cited a Moderate Buy consensus with a slight downside from its average price target, while Jailendra Singh maintained a Hold rating for Tela

Tone
Neutral 50/100
Event
Analyst action
Published
03 Jul 2026 11:39
Source
The Globe and Mail
Kavout | AI Direct company coverage

Teladoc Health: A Rally Built on Shaky Foundations

Teladoc Health's stock has surged, nearing 52-week highs, despite underlying financial woes like declining revenue in its BetterHelp segment and persistent unprofitability. The company faces significant challenges, including a heavy debt load and a negative revenue growth rate fo

Tone
Negative 19/100
Event
Earnings
Published
03 Jul 2026 04:39
Source
Kavout | AI
Market source Direct company coverage

Teladoc's Recovery Story Is Starting to Take Shape. Should You Buy the Stock?

Teladoc Health's stock is up 28% year-to-date, outperforming the S&P 500, despite a 2% revenue decline in Q1 and continued unprofitability. The market is reacting positively to developments like increased insurance coverage for BetterHelp and international expansion, alongside AI

Tone
Neutral 50/100
Event
Earnings
Published
02 Jul 2026 23:20
Source
Market source